Dr. Arthur Tzianabos
Infertility drug developers OvaScience has appointed Dr. Arthur Tzianabos to the position of Chief Scientific Officer.
Tzianabos has over 20 years of experience in the industry and arrives at OvaScience from discovery and development of new therapeutics at Shire Human Genetic Therapies.
According to OvaScience CEO Dr. Michelle Dipp:“Arthur’s success in driving major scientific discoveries through clinical development to commercialization, and his diverse technical background in cell biology, will make him an excellent addition to our team.”